{"entity":{"type":"insider","cik":"0001559779","url":"/insider/0001559779","json_url":"/insider/0001559779.json","name":"Egholm Michael","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":8,"first":"2013-01-14","last":"2025-05-28","span_basis":"filed_date"},"name_variants":[{"name":"Egholm Michael","source":"filing","n_filings":8,"first_seen":"2013-01-14","last_seen":"2025-05-28"}],"transactions":[{"id":4165422,"accession":"0000950170-25-078457","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-078457","line_url":"/filing/0000950170-25-078457#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":"0001559779","owner_name":"Egholm Michael","owner_url":"/insider/0001559779","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5473.0,"shares_display":"5,473","price_per_share":0.941,"price_display":"0.94","price_state":"stated","total_value":5150.093,"total_display":"5,150.09","shares_owned_after":2741191.0,"shares_owned_after_display":"2,741,191","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-23","filed_date":"2025-05-28","scope":"insider"},{"id":4377375,"accession":"0000950170-25-078043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-078043","line_url":"/filing/0000950170-25-078043#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":"0001559779","owner_name":"Egholm Michael","owner_url":"/insider/0001559779","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5116.0,"shares_display":"5,116","price_per_share":1.002,"price_display":"1.00","price_state":"stated","total_value":5126.232,"total_display":"5,126.23","shares_owned_after":2746664.0,"shares_owned_after_display":"2,746,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-22","filed_date":"2025-05-27","scope":"insider"},{"id":4946494,"accession":"0000950170-25-076591","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-076591","line_url":"/filing/0000950170-25-076591#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":"0001559779","owner_name":"Egholm Michael","owner_url":"/insider/0001559779","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4719.0,"shares_display":"4,719","price_per_share":1.03,"price_display":"1.03","price_state":"stated","total_value":4860.57,"total_display":"4,860.57","shares_owned_after":2751780.0,"shares_owned_after_display":"2,751,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-21","filed_date":"2025-05-22","scope":"insider"},{"id":8244532,"accession":"0001127602-15-021619","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001127602-15-021619","line_url":"/filing/0001127602-15-021619#line-6","is_derivative":false,"issuer_cik":"0000075829","issuer_name":"PALL CORP","issuer_ticker":"PLL","issuer_name_source":null,"issuer_url":"/issuer/0000075829","owner_cik":"0001559779","owner_name":"Egholm Michael","owner_url":"/insider/0001559779","role":"Officer (President, BioPharmaceuticals)","officer_title":"President, BioPharmaceuticals","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8147.0,"shares_display":"8,147","price_per_share":124.5461,"price_display":"124.55","price_state":"stated","total_value":1014677.0767,"total_display":"1,014,677.08","shares_owned_after":2407.664,"shares_owned_after_display":"2,407.66","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-29","filed_date":"2015-06-30","scope":"insider"},{"id":8244527,"accession":"0001127602-15-021619","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-15-021619","line_url":"/filing/0001127602-15-021619#line-5","is_derivative":false,"issuer_cik":"0000075829","issuer_name":"PALL CORP","issuer_ticker":"PLL","issuer_name_source":null,"issuer_url":"/issuer/0000075829","owner_cik":"0001559779","owner_name":"Egholm Michael","owner_url":"/insider/0001559779","role":"Officer (President, BioPharmaceuticals)","officer_title":"President, BioPharmaceuticals","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4984.0,"shares_display":"4,984","price_per_share":124.554,"price_display":"124.55","price_state":"stated","total_value":620777.136,"total_display":"620,777.14","shares_owned_after":10554.664,"shares_owned_after_display":"10,554.66","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-29","filed_date":"2015-06-30","scope":"insider"},{"id":8244524,"accession":"0001127602-15-021619","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-15-021619","line_url":"/filing/0001127602-15-021619#line-4","is_derivative":false,"issuer_cik":"0000075829","issuer_name":"PALL CORP","issuer_ticker":"PLL","issuer_name_source":null,"issuer_url":"/issuer/0000075829","owner_cik":"0001559779","owner_name":"Egholm Michael","owner_url":"/insider/0001559779","role":"Officer (President, BioPharmaceuticals)","officer_title":"President, BioPharmaceuticals","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2407.0,"shares_display":"2,407","price_per_share":124.55,"price_display":"124.55","price_state":"stated","total_value":299791.85,"total_display":"299,791.85","shares_owned_after":0.664,"shares_owned_after_display":"0.66","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-29","filed_date":"2015-06-30","scope":"insider"},{"id":6930853,"accession":"0001127602-14-035969","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-14-035969","line_url":"/filing/0001127602-14-035969#line-5","is_derivative":false,"issuer_cik":"0000075829","issuer_name":"PALL CORP","issuer_ticker":"PLL","issuer_name_source":null,"issuer_url":"/issuer/0000075829","owner_cik":"0001559779","owner_name":"Egholm Michael","owner_url":"/insider/0001559779","role":"Officer (President, BioPharmaceuticals)","officer_title":"President, BioPharmaceuticals","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4815.0,"shares_display":"4,815","price_per_share":100.38,"price_display":"100.38","price_state":"stated","total_value":483329.7,"total_display":"483,329.70","shares_owned_after":0.664,"shares_owned_after_display":"0.66","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-22","filed_date":"2014-12-23","scope":"insider"},{"id":6930850,"accession":"0001127602-14-035969","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-14-035969","line_url":"/filing/0001127602-14-035969#line-4","is_derivative":false,"issuer_cik":"0000075829","issuer_name":"PALL CORP","issuer_ticker":"PLL","issuer_name_source":null,"issuer_url":"/issuer/0000075829","owner_cik":"0001559779","owner_name":"Egholm Michael","owner_url":"/insider/0001559779","role":"Officer (President, BioPharmaceuticals)","officer_title":"President, BioPharmaceuticals","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1467.0,"shares_display":"1,467","price_per_share":100.46,"price_display":"100.46","price_state":"stated","total_value":147374.82,"total_display":"147,374.82","shares_owned_after":6120.664,"shares_owned_after_display":"6,120.66","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-22","filed_date":"2014-12-23","scope":"insider"},{"id":6930845,"accession":"0001127602-14-035969","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-14-035969","line_url":"/filing/0001127602-14-035969#line-3","is_derivative":false,"issuer_cik":"0000075829","issuer_name":"PALL CORP","issuer_ticker":"PLL","issuer_name_source":null,"issuer_url":"/issuer/0000075829","owner_cik":"0001559779","owner_name":"Egholm Michael","owner_url":"/insider/0001559779","role":"Officer (President, BioPharmaceuticals)","officer_title":"President, BioPharmaceuticals","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1305.0,"shares_display":"1,305","price_per_share":100.38,"price_display":"100.38","price_state":"stated","total_value":130995.9,"total_display":"130,995.90","shares_owned_after":4815.664,"shares_owned_after_display":"4,815.66","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-22","filed_date":"2014-12-23","scope":"insider"},{"id":6633667,"accession":"0001127602-14-023375","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001127602-14-023375","line_url":"/filing/0001127602-14-023375#line-8","is_derivative":false,"issuer_cik":"0000075829","issuer_name":"PALL CORP","issuer_ticker":"PLL","issuer_name_source":null,"issuer_url":"/issuer/0000075829","owner_cik":"0001559779","owner_name":"Egholm Michael","owner_url":"/insider/0001559779","role":"Officer (Chief Technology Officer)","officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1300.0,"shares_display":"1,300","price_per_share":82.04,"price_display":"82.04","price_state":"stated","total_value":106652.0,"total_display":"106,652.00","shares_owned_after":0.33,"shares_owned_after_display":"0.33","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-14","filed_date":"2014-07-16","scope":"insider"},{"id":6633664,"accession":"0001127602-14-023375","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001127602-14-023375","line_url":"/filing/0001127602-14-023375#line-7","is_derivative":false,"issuer_cik":"0000075829","issuer_name":"PALL CORP","issuer_ticker":"PLL","issuer_name_source":null,"issuer_url":"/issuer/0000075829","owner_cik":"0001559779","owner_name":"Egholm Michael","owner_url":"/insider/0001559779","role":"Officer (Chief Technology Officer)","officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":652.0,"shares_display":"652","price_per_share":82.03,"price_display":"82.03","price_state":"stated","total_value":53483.56,"total_display":"53,483.56","shares_owned_after":0.33,"shares_owned_after_display":"0.33","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-14","filed_date":"2014-07-16","scope":"insider"},{"id":6633661,"accession":"0001127602-14-023375","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001127602-14-023375","line_url":"/filing/0001127602-14-023375#line-6","is_derivative":false,"issuer_cik":"0000075829","issuer_name":"PALL CORP","issuer_ticker":"PLL","issuer_name_source":null,"issuer_url":"/issuer/0000075829","owner_cik":"0001559779","owner_name":"Egholm Michael","owner_url":"/insider/0001559779","role":"Officer (Chief Technology Officer)","officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":625.0,"shares_display":"625","price_per_share":82.01,"price_display":"82.01","price_state":"stated","total_value":51256.25,"total_display":"51,256.25","shares_owned_after":1300.33,"shares_owned_after_display":"1,300.33","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-14","filed_date":"2014-07-16","scope":"insider"},{"id":5536340,"accession":"0001140361-13-011519","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-13-011519","line_url":"/filing/0001140361-13-011519#line-2","is_derivative":false,"issuer_cik":"0000075829","issuer_name":"PALL CORP","issuer_ticker":"PLL","issuer_name_source":null,"issuer_url":"/issuer/0000075829","owner_cik":"0001559779","owner_name":"Egholm Michael","owner_url":"/insider/0001559779","role":"Officer (Chief Technology Officer)","officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2235.0,"shares_display":"2,235","price_per_share":67.81,"price_display":"67.81","price_state":"stated","total_value":151555.35,"total_display":"151,555.35","shares_owned_after":707.333,"shares_owned_after_display":"707.33","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-07","filed_date":"2013-03-08","scope":"insider"},{"id":5536337,"accession":"0001140361-13-011519","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-13-011519","line_url":"/filing/0001140361-13-011519#line-1","is_derivative":false,"issuer_cik":"0000075829","issuer_name":"PALL CORP","issuer_ticker":"PLL","issuer_name_source":null,"issuer_url":"/issuer/0000075829","owner_cik":"0001559779","owner_name":"Egholm Michael","owner_url":"/insider/0001559779","role":"Officer (Chief Technology Officer)","officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":707.0,"shares_display":"707","price_per_share":67.82,"price_display":"67.82","price_state":"stated","total_value":47948.74,"total_display":"47,948.74","shares_owned_after":0.333,"shares_owned_after_display":"0.33","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-07","filed_date":"2013-03-08","scope":"insider"},{"id":5155442,"accession":"0001140361-13-002023","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001140361-13-002023","line_url":"/filing/0001140361-13-002023#line-5","is_derivative":false,"issuer_cik":"0000075829","issuer_name":"PALL CORP","issuer_ticker":"PLL","issuer_name_source":null,"issuer_url":"/issuer/0000075829","owner_cik":"0001559779","owner_name":"Egholm Michael","owner_url":"/insider/0001559779","role":"Officer (Chief Technology Officer)","officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":845.0,"shares_display":"845","price_per_share":64.2,"price_display":"64.20","price_state":"stated","total_value":54249.0,"total_display":"54,249.00","shares_owned_after":1040.0,"shares_owned_after_display":"1,040","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-10","filed_date":"2013-01-14","scope":"insider"},{"id":5155437,"accession":"0001140361-13-002023","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-13-002023","line_url":"/filing/0001140361-13-002023#line-4","is_derivative":false,"issuer_cik":"0000075829","issuer_name":"PALL CORP","issuer_ticker":"PLL","issuer_name_source":null,"issuer_url":"/issuer/0000075829","owner_cik":"0001559779","owner_name":"Egholm Michael","owner_url":"/insider/0001559779","role":"Officer (Chief Technology Officer)","officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":64.22,"price_display":"64.22","price_state":"stated","total_value":38532.0,"total_display":"38,532.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-10","filed_date":"2013-01-14","scope":"insider"},{"id":5155428,"accession":"0001140361-13-002023","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-13-002023","line_url":"/filing/0001140361-13-002023#line-3","is_derivative":false,"issuer_cik":"0000075829","issuer_name":"PALL CORP","issuer_ticker":"PLL","issuer_name_source":null,"issuer_url":"/issuer/0000075829","owner_cik":"0001559779","owner_name":"Egholm Michael","owner_url":"/insider/0001559779","role":"Officer (Chief Technology Officer)","officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":440.0,"shares_display":"440","price_per_share":64.21,"price_display":"64.21","price_state":"stated","total_value":28252.4,"total_display":"28,252.40","shares_owned_after":600.0,"shares_owned_after_display":"600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-10","filed_date":"2013-01-14","scope":"insider"},{"id":5155424,"accession":"0001140361-13-002023","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-13-002023","line_url":"/filing/0001140361-13-002023#line-2","is_derivative":false,"issuer_cik":"0000075829","issuer_name":"PALL CORP","issuer_ticker":"PLL","issuer_name_source":null,"issuer_url":"/issuer/0000075829","owner_cik":"0001559779","owner_name":"Egholm Michael","owner_url":"/insider/0001559779","role":"Officer (Chief Technology Officer)","officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40.0,"shares_display":"40","price_per_share":64.195,"price_display":"64.20","price_state":"stated","total_value":2567.8,"total_display":"2,567.80","shares_owned_after":1885.0,"shares_owned_after_display":"1,885","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-10","filed_date":"2013-01-14","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":18,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001162194","name":"STANDARD BIOTOOLS INC.","url":"/issuer/0001162194","role":"Director, Officer (President & CEO)","n_filings":3,"first_seen":"2025-05-22","last_seen":"2025-05-28"},{"type":"issuer","type_label":"ISSUER","cik":"0000075829","name":"PALL CORP","url":"/issuer/0000075829","role":"Officer (President, BioPharmaceuticals)","n_filings":5,"first_seen":"2013-01-14","last_seen":"2015-06-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001559779","retrieved_at":"2026-08-22T03:35:51+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}